LARGE-CELL LYMPHOMA

Clinical trials for LARGE-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new LARGE-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for LARGE-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 1

New cell therapy aims to wipe out lingering lymphoma before it returns

Disease control Not yet recruiting

This early-phase trial tests a personalized cell therapy (rapcabtagene autoleucel) in 20 adults with large B-cell lymphoma who still have traces of cancer after initial treatment. The goal is to see if the therapy can make those traces disappear, potentially lowering the risk of …

Matched conditions: LARGE-CELL LYMPHOMA

Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC

LARGE-CELL LYMPHOMA

Get alerted when new LARGE-CELL LYMPHOMA trials appear

New cell therapy aims to wipe out lingering lymphoma before it returns